Biologics to Treat Substance Use Disorders
Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies, and Enzymes
Springer | Medicine | January 19, 2016 | ISBN-10: 3319231499 | 453 pages | pdf | 11.22 mb
Springer | Medicine | January 19, 2016 | ISBN-10: 3319231499 | 453 pages | pdf | 11.22 mb
Editors: Montoya, Ivan D. (Ed.)
Covers all aspects of vaccines and other biologics employed for treatment of substance use disorders
Discusses novel strategies to optimize the development and efficacy of biologics
Written and edited by experts in the field
About this book
This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs). The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions.
Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
Number of Illustrations and Tables
47 illus., 57 in colour
Topics
Psychopharmacology
Pharmacotherapy
Pharmacology / Toxicology
More info and Hardcover at Springer
Donate to Support :)